
Legend Biotech (LEGN) Financial Statements
Price: $33.46
Market Cap: $3.07B
Avg Volume: 1.31M
Market Cap: $3.07B
Avg Volume: 1.31M
Country: US
Industry: Biotechnology
Sector: Healthcare
Industry: Biotechnology
Sector: Healthcare
Overview of Financial Statements
Financial statements are records that provide an overview of a company's financial performance and position. There are three main types of financial statements:
- Income Statement: Shows the company's revenue, expenses, and profit over a specific period.
- Balance Sheet: Provides a snapshot of the company's assets, liabilities, and equity at a specific point in time.
- Cash Flow Statement: Details the cash inflows and outflows from operating, investing, and financing activities over a period.
This page presents both annual and quarterly data for these financial statements. The charts below provide a visual representation of the key metrics from each statement, helping you to quickly understand the financial health of Legend Biotech.
Income Statement
Breakdown | December 31, 2024 | December 31, 2023 | December 31, 2022 | December 31, 2021 | December 31, 2020 | December 31, 2019 | December 31, 2018 | December 31, 2017 |
---|---|---|---|---|---|---|---|---|
Revenue | $627.24M | $285.14M | $117.00M | $89.79M | $75.68M | $57.26M | $49.13M | $23.59M |
Cost of Revenue | $234.58M | $144.21M | $65.36M | $313.35M | $232.16M | $- | $- | $-96.00K |
Gross Profit | $392.66M | $140.93M | $51.64M | $-223.55M | $-156.48M | $57.26M | $49.13M | $23.69M |
Gross Profit Ratio | 62.60% | 49.42% | 44.14% | -248.97% | -206.78% | 100.00% | 100.00% | 100.41% |
Research and Development Expenses | $413.54M | $382.22M | $335.65M | $313.35M | $232.16M | $161.94M | $60.64M | $8.20M |
General and Administrative Expenses | $136.78M | $106.77M | $80.63M | $46.94M | $23.15M | $6.75M | $2.77M | $1.62M |
Selling and Marketing Expenses | $147.48M | $94.16M | $93.42M | $102.54M | $49.57M | $25.62M | $1.16M | $-217.00K |
Selling General and Administrative Expenses | $284.26M | $200.93M | $174.05M | $149.48M | $72.72M | $32.37M | $3.93M | $1.40M |
Other Expenses | $-1.91M | $- | $2.23M | $-6.07M | $-74.21M | $-1.68M | $-2.00K | $- |
Operating Expenses | $695.90M | $140.93M | $509.70M | $462.83M | $304.88M | $192.63M | $64.20M | $9.60M |
Cost and Expenses | $930.48M | $727.36M | $575.06M | $462.83M | $304.88M | $192.63M | $64.20M | $9.81M |
Interest Income | $61.20M | $54.49M | $8.18M | $971.00K | $2.93M | $4.58M | $6.21M | $1.00K |
Interest Expense | $21.61M | $21.79M | $10.80M | $900.00K | $4.21M | $223.00K | $82.00K | $- |
Depreciation and Amortization | $23.36M | $20.45M | $18.39M | $13.92M | $9.93M | $5.26M | $1.68M | $217.00K |
EBITDA | $-113.16M | $-477.87M | $-416.54M | $-392.38M | $-294.14M | $-124.89M | $149.00K | $14.06M |
EBITDA Ratio | -18.04% | -167.59% | -356.00% | -436.99% | -388.69% | -218.09% | 0.30% | 59.57% |
Operating Income | $-303.24M | $-439.49M | $-455.83M | $-393.02M | $-313.35M | $-130.87M | $-1.53M | $13.78M |
Operating Income Ratio | -48.35% | -154.13% | -389.58% | -437.71% | -414.06% | -228.54% | -3.12% | 58.41% |
Total Other Income Expenses Net | $145.11M | $-80.63M | $10.10M | $-14.17M | $-78.41M | $5.00M | $13.46M | $-40.00K |
Income Before Tax | $-158.13M | $-520.12M | $-445.72M | $-386.21M | $-307.62M | $-130.37M | $-1.62M | $13.84M |
Income Before Tax Ratio | -25.21% | -182.41% | -380.94% | -430.11% | -406.50% | -227.66% | -3.29% | 58.65% |
Income Tax Expense | $18.89M | $-1.86M | $625.00K | $1.00K | $-4.14M | $2.60M | $1.17M | $4.47M |
Net Income | $-177.03M | $-518.25M | $-446.35M | $-386.21M | $-303.48M | $-132.97M | $-2.78M | $9.37M |
Net Income Ratio | -28.22% | -181.75% | -381.48% | -430.12% | -401.02% | -232.21% | -5.67% | 39.69% |
EPS | $-0.97 | $-2.94 | $-2.81 | $-2.74 | $-2.57 | $-1.01 | $-0.03 | $0.07 |
EPS Diluted | $-0.97 | $-2.94 | $-2.81 | $-2.74 | $-2.57 | $-1.01 | $-0.03 | $0.07 |
Weighted Average Shares Outstanding | 182.85M | 176.08M | 159.04M | 140.85M | 118.15M | 132.01M | 100.00M | 132.01M |
Weighted Average Shares Outstanding Diluted | 182.85M | 176.08M | 159.04M | 140.85M | 118.15M | 132.01M | 100.21M | 132.01M |
SEC Filing | Source | Source | Source | Source | Source | Source | Source | Source |
Balance Sheet
Breakdown | December 31, 2024 | December 31, 2023 | December 31, 2022 | December 31, 2021 | December 31, 2020 | December 31, 2019 | December 31, 2018 | December 31, 2017 |
---|---|---|---|---|---|---|---|---|
Cash and Cash Equivalents | $286.75M | $1.28B | $786.03M | $688.94M | $455.69M | $83.36M | $210.17M | $2.12M |
Short Term Investments | $835.93M | $31.00M | $239.62M | $193.46M | $50.00M | $75.56M | $6.01M | $- |
Cash and Short Term Investments | $1.12B | $1.31B | $1.03B | $882.39M | $505.69M | $158.92M | $216.18M | $2.12M |
Net Receivables | $124.89M | $157.06M | $45.52M | $50.50M | $75.62M | $35.76M | $108.57M | $227.98M |
Inventory | $23.90M | $19.43M | $10.35M | $1.75M | $1.80M | $1.16M | $1.14M | $11.00K |
Other Current Assets | $12.44M | $12.59M | $62.84M | $15.20M | $10.84M | $11.27M | $1.07M | $791.00K |
Total Current Assets | $1.28B | $1.50B | $1.10B | $948.75M | $592.86M | $207.10M | $326.96M | $230.90M |
Property Plant Equipment Net | $201.59M | $189.68M | $161.67M | $155.08M | $121.32M | $75.46M | $33.12M | $2.93M |
Goodwill | $- | $- | $- | $- | $-4.85M | $- | $- | $- |
Intangible Assets | $174.22M | $4.06M | $3.41M | $4.68M | $7.70M | $5.15M | $49.00K | $2.00K |
Goodwill and Intangible Assets | $174.22M | $4.06M | $3.41M | $4.68M | $2.85M | $5.15M | $49.00K | $2.00K |
Long Term Investments | $4.36M | $4.36M | $395.00K | $4.71M | $- | $- | $-1.24M | $-4.86M |
Tax Assets | $- | $285.00K | $-395.00K | $- | $- | $- | $68.92M | $4.86M |
Other Non-Current Assets | $6.06M | $152.42M | $66.76M | $5.15M | $3.97M | $- | $1.24M | $4.86M |
Total Non-Current Assets | $386.24M | $350.81M | $231.84M | $169.62M | $128.15M | $80.61M | $102.09M | $7.79M |
Other Assets | $- | $- | $- | $- | $- | $- | $- | $1 |
Total Assets | $1.67B | $1.85B | $1.33B | $1.12B | $721.01M | $287.71M | $429.05M | $238.69M |
Account Payables | $37.19M | $20.16M | $32.89M | $7.04M | $4.91M | $9.59M | $7.32M | $4.33M |
Short Term Debt | $4.79M | $3.17M | $7.13M | $911.00K | $1.46M | $1.03M | $373.00K | $64.00K |
Tax Payables | $24.04M | $7.20M | $9.77M | $515.00K | $8.79M | $- | $74.54M | $9.33M |
Deferred Revenue | $47.41M | $53.01M | $451.00K | $60.95M | $55.30M | $46.29M | $40.32M | $30.21M |
Other Current Liabilities | $164.21M | $132.87M | $248.00M | $220.74M | $100.11M | $70.85M | $36.63M | $38.39M |
Total Current Liabilities | $277.64M | $216.42M | $297.79M | $280.27M | $161.17M | $127.76M | $159.19M | $52.12M |
Long Term Debt | $345.81M | $325.50M | $280.97M | $122.06M | $1.91M | $5.06M | $3.94M | $205.00K |
Deferred Revenue Non-Current | $6.15M | $55.27M | $7.66M | $242.58M | $275.07M | $277.76M | $257.27M | $174.20M |
Deferred Tax Liabilities Non-Current | $- | $- | $- | $1.87M | $2.05M | $-41.99M | $-213.20M | $-174.20M |
Other Non-Current Liabilities | $- | $56.00K | $7.89M | $2.26M | $2.60M | $- | $- | $- |
Total Non-Current Liabilities | $351.96M | $380.82M | $288.86M | $366.89M | $279.58M | $282.82M | $261.21M | $174.40M |
Other Liabilities | $- | $- | $- | $- | $- | $- | $- | $- |
Total Liabilities | $629.61M | $597.24M | $586.65M | $647.16M | $440.75M | $410.58M | $420.40M | $226.53M |
Preferred Stock | $- | $- | $222.14M | $- | $- | $123.35M | $- | $- |
Common Stock | $37.00K | $36.00K | $33.00K | $31.00K | $27.00K | $20.00K | $20.00K | $20.00K |
Retained Earnings | $-1.66B | $-1.48B | $-966.46M | $-816.97M | $-430.76M | $-127.28M | $5.69M | $8.47M |
Accumulated Other Comprehensive Income Loss | $-68.16M | $98.92M | $744.28M | $471.18M | $280.23M | $-122.89M | $8.63M | $-236.00K |
Other Total Stockholders Equity | $2.77B | $2.64B | $1.66B | $1.26B | $708.31M | $5.88M | $3.91M | $3.91M |
Total Stockholders Equity | $1.04B | $1.25B | $744.31M | $471.21M | $280.25M | $-122.87M | $8.65M | $12.17M |
Total Equity | $1.04B | $1.25B | $744.31M | $471.21M | $280.25M | $-122.87M | $8.65M | $12.17M |
Total Liabilities and Stockholders Equity | $1.67B | $1.85B | $1.33B | $1.12B | $721.01M | $287.71M | $429.05M | $238.69M |
Minority Interest | $- | $- | $- | $- | $- | $- | $- | $- |
Total Liabilities and Total Equity | $1.67B | $1.85B | $1.33B | $1.12B | $721.01M | $287.71M | $429.05M | $238.69M |
Total Investments | $840.30M | $35.37M | $239.62M | $198.16M | $50.00M | $75.56M | $6.01M | $-4.86M |
Total Debt | $350.60M | $328.67M | $284.53M | $122.97M | $3.37M | $6.08M | $4.32M | $269.00K |
Net Debt | $63.85M | $-949.04M | $-501.50M | $-565.97M | $-452.32M | $-77.28M | $-205.85M | $-1.85M |
Cash Flow Statement
Breakdown | December 31, 2024 | December 31, 2023 | December 31, 2022 | December 31, 2021 | December 31, 2020 | December 31, 2019 | December 31, 2018 | December 31, 2017 |
---|---|---|---|---|---|---|---|---|
Net Income | $-158.13M | $-518.25M | $-445.72M | $-386.21M | $-307.62M | $-130.37M | $-1.62M | $9.37M |
Depreciation and Amortization | $23.36M | $20.45M | $18.39M | $13.92M | $9.93M | $5.26M | $1.68M | $217.00K |
Deferred Income Tax | $- | $- | $- | $-174.94M | $9.22M | $-7.35M | $-5.66M | $- |
Stock Based Compensation | $68.94M | $47.68M | $34.34M | $20.16M | $4.76M | $1.27M | $704.00K | $- |
Change in Working Capital | $20.04M | $-71.34M | $186.32M | $140.87M | $-23.92M | $52.48M | $318.71M | $-16.50M |
Accounts Receivables | $93.75M | $-98.98M | $50.32M | $24.59M | $-45.00M | $-3.77M | $207.61M | $-228.06M |
Inventory | $-17.21M | $-12.71M | $-8.61M | $51.00K | $-643.00K | $-22.00K | $-1.12M | $-6.00K |
Accounts Payables | $14.06M | $-12.70M | $25.85M | $1.80M | $-4.35M | $2.01M | $3.24M | $4.17M |
Other Working Capital | $-70.57M | $53.04M | $118.75M | $114.42M | $26.07M | $54.27M | $108.99M | $207.40M |
Other Non Cash Items | $-98.24M | $128.19M | $6.65M | $187.74M | $84.62M | $-4.36M | $-6.13M | $228.87M |
Net Cash Provided by Operating Activities | $-144.03M | $-393.28M | $-200.03M | $-198.47M | $-223.00M | $-83.06M | $307.68M | $-2.38M |
Investments in Property Plant and Equipment | $-14.11M | $-20.08M | $-22.27M | $-47.11M | $-49.78M | $-39.17M | $-21.02M | $-887.00K |
Acquisitions Net | $- | $- | $- | $3.21M | $4.03M | $-460.00K | $20.00K | $60.00K |
Purchases of Investments | $-2.71B | $-4.86B | $-654.97M | $-377.96M | $-72.68M | $-390.40M | $-6.00M | $- |
Sales Maturities of Investments | $1.93B | $5.07B | $613.61M | $230.08M | $98.29M | $320.85M | $- | $- |
Other Investing Activities | $-54.34M | $-91.70M | $-14.71M | $-3.20M | $-4.03M | $50.52M | $-75.23M | $55.00K |
Net Cash Used for Investing Activities | $-850.54M | $92.79M | $-78.34M | $-194.98M | $-24.17M | $-58.65M | $-102.26M | $-827.00K |
Debt Repayment | $-4.02M | $-3.75M | $-2.60M | $-1.42M | $-2.60M | $-5.06M | $-219.00K | $-32.00K |
Common Stock Issued | $- | $583.69M | $377.64M | $623.44M | $462.08M | $- | $- | $1.43M |
Common Stock Repurchased | $- | $- | $- | $- | $- | $- | $- | $- |
Dividends Paid | $- | $- | $- | $- | $- | $- | $- | $- |
Other Financing Activities | $9.72M | $211.56M | $2.93M | $4.64M | $159.40M | $19.72M | $2.72M | $3.35M |
Net Cash Used Provided by Financing Activities | $5.70M | $791.49M | $377.98M | $626.66M | $618.88M | $14.67M | $2.50M | $3.32M |
Effect of Forex Changes on Cash | $-2.08M | $682.00K | $-2.51M | $34.00K | $620.00K | $249.00K | $124.00K | $9.00K |
Net Change in Cash | $-990.96M | $491.68M | $97.09M | $233.25M | $372.32M | $-126.80M | $208.05M | $128.00K |
Cash at End of Period | $286.75M | $1.28B | $786.03M | $688.94M | $455.69M | $83.36M | $210.17M | $2.12M |
Cash at Beginning of Period | $1.28B | $786.03M | $688.94M | $455.69M | $83.36M | $210.17M | $2.12M | $1.99M |
Operating Cash Flow | $-144.03M | $-393.28M | $-200.03M | $-198.47M | $-223.00M | $-83.06M | $307.68M | $-2.38M |
Capital Expenditure | $-14.11M | $-22.72M | $-22.27M | $-47.11M | $-49.78M | $-39.17M | $-21.02M | $-887.00K |
Free Cash Flow | $-158.14M | $-416.00M | $-222.30M | $-245.58M | $-272.78M | $-122.23M | $286.66M | $-3.26M |